In the early 1980s, clinical differences in response to the blood pressure (BP)-lowering effects of β-blockers and, to a lesser extent, diuretics were noted between ethnic groups. The most convincing evidence at that time came from a Veterans Affairs (VA) Cooperative Trial,1 which, along with other smaller studies, suggested that whites (those of European ancestry)Continue reading “Ethnic Differences in Cardiovascular Drug Response & Pharmacogenetics by Julie A. Johnson, PharmD”